Mesenchymal Stem Cell–Derived Exosomes Improve Functional Recovery in Rats After Traumatic Brain Injury: A Dose-Response and Therapeutic Window Study

Neurorehabilitation and Neural Repair - Tập 34 Số 7 - Trang 616-626 - 2020
Yanlu Zhang1, Yi Zhang1, Michael Chopp1,2, Zheng Gang Zhang1, Asim Mahmood1, Ye Xiong1
1Henry Ford Hospital, Detroit, MI USA
2Oakland University, Rochester, MI, USA

Tóm tắt

Background. Mesenchymal stem cell (MSC)-derived exosomes play a critical role in regenerative medicine. Objective. To determine the dose- and time-dependent efficacy of exosomes for treatment of traumatic brain injury (TBI). Methods. Male rats were subjected to a unilateral moderate cortical contusion. In the dose-response study, animals received a single intravenous injection of exosomes (50, 100, 200 µg per rat) or vehicle, with treatment initiated at 1 day after injury. In the therapeutic window study, animals received a single intravenous injection of 100 µg exosomes or vehicle starting at 1, 4, or 7 days after injury. Neurological functional tests were performed weekly after TBI for 5 weeks. Spatial learning was measured on days 31 to 35 after TBI using the Morris water maze test. Results. Compared with the vehicle, regardless of the dose and delay in treatment, exosome treatment significantly improved sensorimotor and cognitive function, reduced hippocampal neuronal cell loss, promoted angiogenesis and neurogenesis, and reduced neuroinflammation. Exosome treatment at 100 µg per rat exhibited a significant therapeutic effect compared with the 50- or 200-µg exosome groups. The time-dependent exosome treatment data demonstrated that exosome treatment starting at 1 day post-TBI provided a significantly greater improvement in functional and histological outcomes than exosome treatments at the other 2 delayed treatments. Conclusions. These results indicate that exosomes have a wide range of effective doses for treatment of TBI with a therapeutic window of at least 7 days postinjury. Exosomes may provide a novel therapeutic intervention in TBI.

Từ khóa


Tài liệu tham khảo

10.1016/j.amepre.2008.01.011

10.1038/nrn3407

10.1080/14653240802217011

10.1212/WNL.56.12.1666

10.1097/00001756-200103050-00025

10.1016/j.neulet.2008.03.096

10.1016/S1474-4422(02)00040-6

10.4103/1673-5374.198966

Kooijmans SA, 2012, Int J Nanomedicine, 7, 1525

10.1016/j.ccell.2014.09.005

10.3171/2014.11.JNS14770

10.1016/j.neuint.2016.08.003

10.1002/stem.1129

10.3171/2010.4.JNS10118

10.1161/hs1101.098367

10.1016/S0165-0270(03)00212-7

10.3171/2013.3.JNS122061

10.3389/fneur.2017.00028

10.1038/jcbfm.2013.152

10.1073/pnas.1522297113

10.1161/str.49.suppl_1.TMP31

10.1016/j.cjtee.2018.02.003

10.1016/j.neulet.2013.02.046

10.1186/1423-0127-21-5

10.1186/1742-2094-10-106

10.3389/fneur.2013.00018

10.3109/00207454.2011.598981

10.1016/j.expneurol.2012.02.015

10.1227/01.NEU.0000346272.76537.DC

10.1227/01.NEU.0000181369.76323.50

10.3171/2012.11.JNS12753

10.1161/01.STR.32.4.1005

10.1161/STROKEAHA.110.593129

10.1038/sj.jcbfm.9600311

10.1186/s12974-018-1122-8

10.1097/TA.0000000000002563

10.3390/ijms15034142

10.2217/rme.13.4

10.1634/stemcells.2007-0625

10.1038/s41582-018-0126-4

10.3389/fncel.2014.00377

10.1002/stem.1409

10.1089/neu.2018.5711

10.3233/RNN-190910

Xiong Y, 2010, Curr Opin Investig Drugs, 11, 298

Taupin P., 2006, Curr Opin Mol Ther, 8, 225

10.1111/j.1742-4658.2009.07176.x

10.1038/nm1735

10.1523/JNEUROSCI.4323-06.2006

10.1007/s12975-011-0120-2

10.1161/01.STR.0000034399.95249.59

10.1089/neu.2010.1291

von Bartheld C, 2002, Histol Histopathol, 17, 639

10.1002/ar.10111

Thông tin
Thông tin xuất bản

Neurorehabilitation and Neural Repair

Tập 34 Số 7

616-626

Thông tin tác giả